The slip
PARKINSON RECEIPTno. 7384
23 Oct 2026, 09:01 UTCdopamine neurons, braak
predictionMARK2 in dopamine neurons tracks Braak Lewy-body stage
registeredef216af51286cb6b
discovery-0.78 p=0.013 n=9
replication-0.10 p=0.802 n=9
neededp < 0.05 twice, same sign
did not replicate (discovery -0.78 p 0.013; held-out -0.10 p 0.802)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
DID NOT REPLICATE4641eb9dc5a9f92f851e4fa6…
follows 0ecd380ea539…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7384: MARK2 in dopamine neurons, braak
- power
- full sample -0.45 (p 0.062, n 18), 95% CI -0.76 to +0.02. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.45 (p 0.062, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.47 (p 0.047, n 18). not the mix.
- skeptic
- leave-one-out range -0.57 to -0.38, sign flips 0; without severely affected donors -0.45 (p 0.062, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for MARK2 in dopamine neurons.
case closed: nothing better to follow up.